Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Enterprise Value of -$26.7 million for Q1 2026, down 47.0% year-over-year from -$50.4 million in Q1 2025, and up 11.02% quarter-over-quarter from -$30.0 million in Q4 2025.
Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Enterprise Value for 16 consecutive years, with -$26.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 47.0% year-over-year to -$26.7 million; the TTM figure through Mar 2026 stood at -$26.7 million (down 47.0% YoY), while the FY2025 annual figure was -$31.0 million, down 54.71% from the prior year.
- Enterprise Value advanced to -$26.7 million in Q1 2026 per AYTU's latest filing, from -$30.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$18.2 million in Q1 2025 and bottomed at -$32.6 million in Q3 2025.
- Historically, Enterprise Value has averaged -$23.0 million across 5 years, with a median of -$20.1 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 61.4% — and 2025, when it slumped 62.27%.
- Aytu Biopharma's Enterprise Value stood at -$19.5 million in 2022, then decreased by 0.14% to -$19.5 million in 2023, then retreated by 4.45% to -$20.4 million in 2024, then sank by 47.2% to -$30.0 million in 2025, then increased by 11.02% to -$26.7 million in 2026.
- Business Quant data shows AYTU's Enterprise Value at -$26.7 million in Q1 2026, -$30.0 million in Q4 2025, and -$32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | -26.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.72 Mn |
| Dec 31, 2025 | -30.03 Mn |
| Sep 30, 2025 | -32.63 Mn |
| Jun 30, 2025 | -30.95 Mn |
| Mar 31, 2025 | -18.17 Mn |
| Dec 31, 2024 | -20.40 Mn |
| Sep 30, 2024 | -20.11 Mn |
| Jun 30, 2024 | -20.01 Mn |
| Mar 31, 2024 | -19.76 Mn |
| Dec 31, 2023 | -19.53 Mn |
| Sep 30, 2023 | -19.96 Mn |
| Jun 30, 2023 | -22.99 Mn |
| Mar 31, 2023 | -19.18 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -23.81 Mn |
| Jun 30, 2022 | -19.36 Mn |
| Mar 31, 2022 | -27.61 Mn |
| Dec 31, 2021 | -35.28 Mn |
| Sep 30, 2021 | -40.56 Mn |
| Jun 30, 2021 | -50.15 Mn |